JNGLX vs. PRHSX
Compare and contrast key facts about Janus Henderson Global Life Sciences Fund (JNGLX) and T. Rowe Price Health Sciences Fund (PRHSX).
JNGLX is managed by Janus Henderson. It was launched on Dec 30, 1998. PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995.
Performance
JNGLX vs. PRHSX - Performance Comparison
Loading graphics...
JNGLX vs. PRHSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JNGLX Janus Henderson Global Life Sciences Fund | -6.61% | 24.84% | 3.60% | 7.51% | -2.69% | 6.78% | 25.66% | 29.20% | 4.17% | 22.13% |
PRHSX T. Rowe Price Health Sciences Fund | -9.65% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
Returns By Period
In the year-to-date period, JNGLX achieves a -6.61% return, which is significantly higher than PRHSX's -9.65% return. Over the past 10 years, JNGLX has underperformed PRHSX with an annualized return of 10.68%, while PRHSX has yielded a comparatively higher 11.42% annualized return.
JNGLX
- 1D
- 0.29%
- 1M
- -9.20%
- YTD
- -6.61%
- 6M
- 10.83%
- 1Y
- 15.45%
- 3Y*
- 9.57%
- 5Y*
- 6.75%
- 10Y*
- 10.68%
PRHSX
- 1D
- 0.37%
- 1M
- -9.33%
- YTD
- -9.65%
- 6M
- 18.49%
- 1Y
- 20.86%
- 3Y*
- 9.06%
- 5Y*
- 4.83%
- 10Y*
- 11.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
JNGLX vs. PRHSX - Expense Ratio Comparison
Both JNGLX and PRHSX have an expense ratio of 0.80%.
Return for Risk
JNGLX vs. PRHSX — Risk / Return Rank
JNGLX
PRHSX
JNGLX vs. PRHSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund (JNGLX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JNGLX | PRHSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.82 | 0.92 | -0.09 |
Sortino ratioReturn per unit of downside risk | 1.21 | 1.60 | -0.39 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.20 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.29 | 1.52 | -0.24 |
Martin ratioReturn relative to average drawdown | 3.48 | 4.47 | -0.99 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JNGLX | PRHSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.82 | 0.92 | -0.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.43 | 0.27 | +0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.58 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | 0.63 | -0.06 |
Correlation
The correlation between JNGLX and PRHSX is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
JNGLX vs. PRHSX - Dividend Comparison
JNGLX's dividend yield for the trailing twelve months is around 4.89%, less than PRHSX's 26.63% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNGLX Janus Henderson Global Life Sciences Fund | 4.89% | 4.56% | 5.84% | 4.26% | 0.25% | 9.85% | 7.80% | 6.23% | 13.32% | 0.89% | 0.30% | 8.81% |
PRHSX T. Rowe Price Health Sciences Fund | 26.63% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
Drawdowns
JNGLX vs. PRHSX - Drawdown Comparison
The maximum JNGLX drawdown since its inception was -59.00%, which is greater than PRHSX's maximum drawdown of -42.96%. Use the drawdown chart below to compare losses from any high point for JNGLX and PRHSX.
Loading graphics...
Drawdown Indicators
| JNGLX | PRHSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.00% | -42.96% | -16.04% |
Max Drawdown (1Y)Largest decline over 1 year | -9.68% | -12.81% | +3.13% |
Max Drawdown (5Y)Largest decline over 5 years | -22.21% | -27.61% | +5.40% |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | -28.97% | +1.60% |
Current DrawdownCurrent decline from peak | -9.41% | -12.49% | +3.08% |
Average DrawdownAverage peak-to-trough decline | -17.73% | -8.75% | -8.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.98% | 4.36% | -0.38% |
Volatility
JNGLX vs. PRHSX - Volatility Comparison
The current volatility for Janus Henderson Global Life Sciences Fund (JNGLX) is 4.89%, while T. Rowe Price Health Sciences Fund (PRHSX) has a volatility of 5.30%. This indicates that JNGLX experiences smaller price fluctuations and is considered to be less risky than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JNGLX | PRHSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.89% | 5.30% | -0.41% |
Volatility (6M)Calculated over the trailing 6-month period | 10.23% | 15.97% | -5.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.63% | 22.33% | -4.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.64% | 18.01% | -2.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.40% | 19.65% | -2.25% |